Keyphrases
Conjunctival
98%
Platelet-rich Fibrin Membrane
96%
Transforming Growth Factor-β
77%
Platelet-rich Fibrin
62%
Conjunctival Autograft
56%
Wound Healing
50%
Open Globe Injury
50%
Excision
50%
Triamcinolone Acetonide
46%
Type I Collagen
42%
Inflammation
41%
Treatment Group
37%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
37%
Pseudomonas Aeruginosa Keratitis
37%
Resveratrol
37%
Fibrin Glue
37%
α-smooth muscle Actin (α-SMA)
37%
Matrix metalloproteinase-9 (MMP-9)
37%
Fibrosis
31%
Mitomycin C
30%
Interleukin-1β
28%
Intravitreal
27%
Proliferative Vitreoretinopathy
27%
Bevacizumab
27%
Intravitreal Triamcinolone Acetonide Injection
25%
Intravitreal Ranibizumab
25%
Corneal Wound Healing
25%
Strabismus Surgery
25%
Retinal Ganglion Cell Loss
25%
Asiatic Acid
25%
Contracted Socket
25%
Collagen Type III
25%
Phacoemulsification
25%
Ischemia-reperfusion Injury
25%
Alkali Burn
25%
Cataract
25%
Indonesia
23%
Collagen Expression
23%
Growth Factors
22%
Vascular Endothelial Growth Factor
21%
Cornea
21%
New Zealand White Rabbit
20%
Microbial Keratitis
20%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
20%
Plasminogen Activator inhibitor-1 (PAI-1)
18%
Cell Proliferation
18%
Antifibrotic
18%
Right Eye
17%
Apoptosis
17%
Surabaya
17%
Corticosteroids
16%
Healing
16%
Eyeball
16%
Tumor Necrosis Factor-α
15%
Oryctolagus Cuniculus
15%
Myofibroblast
15%
Rattus Norvegicus
15%
Matrix metalloproteinase-3 (MMP-3)
15%
Conjunctiva
14%
Cellular Expression
14%
Retinal Ganglion Cells
14%
Glaucoma
14%
Academic Hospital
13%
Intraocular Pressure
12%
Injury Model
12%
Scar Remodeling
12%
Human Pterygium Fibroblasts
12%
Cutaneous Wound Healing
12%
Conditioned Medium
12%
Online Methods
12%
Intravitreal Administration
12%
Ophthalmology Residents
12%
Interleukin-6 Expression
12%
Capsular Contraction Syndrome
12%
Nd-YAG Laser Capsulotomy
12%
Hyperopic Shift
12%
Neutrophil Count
12%
Growth Form
12%
Model Experimental
12%
Parental Risk Factors
12%
Epigallocatechin Gallate
12%
Dexamethasone Administration
12%
Extraocular muscles
12%
Phacotrabeculectomy
12%
Moxifloxacin
12%
Primary Angle-closure Glaucoma
12%
Vascular Density
12%
Na +
12%
Hypothermic Perfusion
12%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
12%
Beneficial Effects
12%
Novel Therapies
12%
VEGF Expression
12%
Objective Structured Clinical Examination
12%
Complete Resolution
12%
Neuroprotective Agents
12%
Collagen Type 1
12%
Collagen Type I
12%
Myopia
12%
MMC
12%
Medicine and Dentistry
Platelet-Rich Fibrin
100%
Wound Healing
53%
Strabismus Surgery
50%
Asiatic Acid
50%
Fibrosis
47%
Vasculotropin
43%
Triamcinolone Acetonide
43%
Autograft
41%
Transforming Growth Factor Beta
40%
Fibrin Glue
37%
Gelatinase B
37%
Collagen Type 1
37%
Dexamethasone
33%
Cancer Growth Factor
30%
Mitomycin
30%
Pseudomonas aeruginosa
30%
Treatment Group
28%
Fibroblast
28%
Keratitis
27%
Bevacizumab
25%
Corneal Wound Healing
25%
Phacoemulsification
25%
Smooth Muscle Actin
25%
Cataract
25%
Strabismus
20%
Wound
18%
Bacterial Keratitis
17%
Cell Proliferation
17%
Centella asiatica
17%
Eyeball
15%
Intraocular Pressure
15%
Interleukin 1
15%
Programmed Cell Death
15%
Clinical Examination
15%
Antifibrotic Agent
15%
Interleukin 4
15%
Tumor Necrosis Factor
14%
Amnion
14%
Subconjunctival Drug Administration
12%
Metalloprotease Inhibitor
12%
Nd:YAG Laser
12%
Collagen Type 3
12%
Proliferative Vitreoretinopathy
12%
Tissue Inhibitor of Metalloproteinase 1
12%
Cell Loss
12%
Extraocular Muscle
12%
Sodium Ion
12%
Endothelium Cell
12%
Closed Angle Glaucoma
12%
Adenosine Triphosphatase (Potassium)
12%
Ophthalmology
12%
Ganglion
12%
Corneal Endothelium
12%
Antiapoptotic
12%
Reperfusion Injury
12%
Capsulotomy
12%
Pterygium
12%
Curcumin
12%
Mononuclear Cell
12%
Resveratrol
12%
Cell Density
12%
Symblepharon
12%
Caustic Burn
12%
Senile Cataract
12%
Epithelial Cell
12%
Glutathione Reductase
12%
Sodium Hydroxide
12%
Peters Anomaly
12%
Cornea Opacity
12%
Cell Count
12%
Eosinophil
12%
Endocrine Ophthalmopathy
12%
Ocular Tuberculosis
12%
Anti-Inflammatory Drug
11%
Glaucoma
10%
Caspase 3
10%
Intravitreal Administration
10%
Matrix Metalloproteinase
9%
Surgical Technique
9%
Growth Factor
8%
Ocular Surface
8%
Endothelial Cell
8%
Inflammatory Cytokine
8%
Visual Impairment
8%
Diseases
8%
Immunohistochemistry
7%
Phosphate Buffered Saline
7%
Visual Acuity
6%
Angiogenesis
6%
Neuroprotective Agent
6%
Balanced Salt Solution
6%
Inflammatory Cell
6%
Rank Sum Test
6%
Traditional Medicine
6%
Saponin
6%
Adjuvant Therapy
6%
Incision
5%
Sclera
5%
Recurrent Disease
5%
Homeostasis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Platelet-Rich Fibrin
100%
Vasculotropin
70%
Wound Healing
58%
Triamcinolone Acetonide
56%
Transforming Growth Factor Beta
50%
Strabismus
50%
Asiatic Acid
50%
Inflammation
49%
Fibrosis
49%
Pseudomonas aeruginosa
42%
Keratitis
40%
Bevacizumab
38%
Fibrin Glue
37%
Gelatinase B
37%
Leporidae
34%
Dexamethasone
31%
Mitomycin
30%
Treatment Group
29%
Vitreoretinopathy
28%
Cornea Injury
28%
Interleukin 1
27%
Interleukin 6
27%
Smooth Muscle Actin
25%
Collagen Type 1
25%
Reperfusion Injury
25%
Resveratrol
25%
Chemical Injury
25%
Tumor Necrosis Factor
24%
Intravitreal Administration
23%
Wound
21%
Cancer Growth Factor
18%
Plasminogen Activator Inhibitor 1
17%
Neuroprotective Agent
17%
Bacterial Keratitis
17%
Oryctolagus cuniculus
15%
Rattus norvegicus
15%
Antifibrotic Agent
15%
Interleukin 4
15%
New Zealand Rabbit
14%
Tissue Inhibitor of Metalloproteinase
12%
Pterygium
12%
Collagen Type 3
12%
Tissue Inhibitor of Metalloproteinase 1
12%
Epigallocatechin Gallate
12%
Moxifloxacin
12%
Antiapoptotic
12%
Curcumin
12%
Symblepharon
12%
Caustic Burn
12%
Experimental Animal
12%
Sodium Hydroxide
12%
Open Angle Glaucoma
12%
Centella asiatica
12%
Caspase 3
11%
Anti-Inflammatory Drug
10%
Matrix Metalloproteinase
9%
Cytokine
9%
New Zealand White (Rabbit)
9%
Glaucoma Medication
8%
Cornea Perforation
8%
Phosphate Buffered Saline
7%
Eye Injury
7%
Growth Factor
7%
Side Effect
6%
Actin
6%
Endophthalmitis
6%
Glaucoma
5%
Diseases
5%
Visual Impairment
5%
Recurrent Disease
5%
Retina Detachment
5%